...
首页> 外文期刊>Medical Physics >Automatic 3D registration of dynamic stress and rest (82)Rb and flurpiridaz F 18 myocardial perfusion PET data for patient motion detection and correction.
【24h】

Automatic 3D registration of dynamic stress and rest (82)Rb and flurpiridaz F 18 myocardial perfusion PET data for patient motion detection and correction.

机译:自动进行3D动态应力和静息(82)Rb和flurpiridaz F 18心肌灌注PET数据的配准,以检测和纠正患者的运动。

获取原文
获取原文并翻译 | 示例
           

摘要

PURPOSE: The authors aimed to develop an image-based registration scheme to detect and correct patient motion in stress and rest cardiac positron emission tomography (PET)/CT images. The patient motion correction was of primary interest and the effects of patient motion with the use of flurpiridaz F 18 and (82)Rb were demonstrated. METHODS: The authors evaluated stress/rest PET myocardial perfusion imaging datasets in 30 patients (60 datasets in total, 21 male and 9 female) using a new perfusion agent (flurpiridaz F 18) (n = 16) and (82)Rb (n = 14), acquired on a Siemens Biograph-64 scanner in list mode. Stress and rest images were reconstructed into 4 ((82)Rb) or 10 (flurpiridaz F 18) dynamic frames (60 s each) using standard reconstruction (2D attenuation weighted ordered subsets expectation maximization). Patient motion correction was achieved by an image-based registration scheme optimizing a cost function using modified normalized cross-correlation that combined global and local features. For comparison, visual scoring of motion was performed on the scale of 0 to 2 (no motion, moderate motion, and large motion) by two experienced observers. RESULTS: The proposed registration technique had a 93% success rate in removing left ventricular motion, as visually assessed. The maximum detected motion extent for stress and rest were 5.2 mm and 4.9 mm for flurpiridaz F 18 perfusion and 3.0 mm and 4.3 mm for (82)Rb perfusion studies, respectively. Motion extent (maximum frame-to-frame displacement) obtained for stress and rest were (2.2 +/- 1.1, 1.4 +/- 0.7, 1.9 +/- 1.3) mm and (2.0 +/- 1.1, 1.2 +/-0 .9, 1.9 +/- 0.9) mm for flurpiridaz F 18 perfusion studies and (1.9 +/- 0.7, 0.7 +/- 0.6, 1.3 +/- 0.6) mm and (2.0 +/- 0.9, 0.6 +/- 0.4, 1.2 +/- 1.2) mm for (82)Rb perfusion studies, respectively. A visually detectable patient motion threshold was established to be >/=2.2 mm, corresponding to visual user scores of 1 and 2. After motion correction, the average increases in contrast-to-noise ratio (CNR) from all frames for larger than the motion threshold were 16.2% in stress flurpiridaz F 18 and 12.2% in rest flurpiridaz F 18 studies. The average increases in CNR were 4.6% in stress (82)Rb studies and 4.3% in rest (82)Rb studies. CONCLUSIONS: Fully automatic motion correction of dynamic PET frames can be performed accurately, potentially allowing improved image quantification of cardiac PET data.
机译:目的:作者旨在开发一种基于图像的配准方案,以检测和纠正患者在压力和静息心脏正电子发射断层扫描(PET)/ CT图像中的运动。病人运动矫正是最主要的兴趣,并证明了使用flurpiridaz F 18和(82)Rb对病人运动的影响。方法:作者使用新的灌注剂(flurpiridaz F 18)(n = 16)和(82)Rb(n)对30例患者的压力/静息PET心肌灌注成像数据集进行了评估(总共60个数据集,男性21位,女性9位)。 = 14),是在西门子Biograph-64扫描仪上以列表模式获取的。使用标准重建(2D衰减加权有序子集期望最大化),将压力和静止图像重​​建为4个((82)Rb)或10个(flurpiridaz F 18)动态帧(每个60 s)。患者的运动校正是通过基于图像的配准方案实现的,该方案使用组合了全局和局部特征的修正归一化互相关来优化成本函数。为了进行比较,两名经验丰富的观察者以0到2(无运动,中度运动和大运动)的比例对运动进行了视觉评分。结果:通过视觉评估,所提出的配准技术在去除左心室运动方面具有93%的成功率。对于氟吡哌唑F 18灌注,检测到的最大压力运动和静息运动程度分别为5.2 mm和4.9 mm,对于(82)Rb灌注研究,分别为3.0 mm和4.3 mm。应力和静止所获得的运动范围(最大帧到帧位移)为(2.2 +/- 1.1、1.4 +/- 0.7、1.9 +/- 1.3)mm和(2.0 +/- 1.1、1.2 +/- 0)氟哌啶酮F 18灌注研究的.9,1.9 +/- 0.9)mm和(1.9 +/- 0.7,0.7 +/- 0.6,1.3 +/- 0.6)mm和(2.0 +/- 0.9,0.6 +/- 0.4 (82)Rb灌注研究分别为1.2 +/- 1.2)mm。视觉上可检测到的患者运动阈值被设置为> / = 2.2 mm,对应于视觉用户得分1和2。运动校正后,所有帧的对比度和噪声比(CNR)的平均增加大于运动应激阈值flurpiridaz F 18的运动阈值为16.2%,其余flurpiridaz F 18研究的运动阈值为12.2%。压力(82)Rb研究中CNR的平均增加为4.6%,其余(82)Rb研究中CNR的平均增加为4.3%。结论:可以精确地执行动态PET帧的全自动运动校正,从而可能改善心脏PET数据的图像量化。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号